BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9876481)

  • 41. Cancer chemotherapy-related symptoms: evidence to suggest a role for proinflammatory cytokines.
    Wood LJ; Nail LM; Gilster A; Winters KA; Elsea CR
    Oncol Nurs Forum; 2006 May; 33(3):535-42. PubMed ID: 16676010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer-associated malnutrition.
    Argilés JM
    Eur J Oncol Nurs; 2005; 9 Suppl 2():S39-50. PubMed ID: 16437757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous cachectin/tumour necrosis factor-alpha production contributes to experimental cancer-associated cachexia.
    Moldawer LL; Sherry B; Lowry SF; Cerami A
    Cancer Surv; 1989; 8(4):853-9. PubMed ID: 2701731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of animal models for head and neck cancer cachexia.
    Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
    Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Omega-3 fatty acid effects on biochemical indices following cancer surgery.
    Stehr SN; Heller AR
    Clin Chim Acta; 2006 Nov; 373(1-2):1-8. PubMed ID: 16796997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cachexia, malignancy and tumor necrosis factor alpha (TNF-alpha)].
    Nussinovitch U; Shoenfeld Y
    Harefuah; 2007 May; 146(5):349-51, 406. PubMed ID: 17674550
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-alpha, VEGF-A, VEGF-C and midkine in gastroesophageal cancer patients.
    Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Blachut K; Kustrzeba-Wojcicka I; Banas T
    Clin Biochem; 2007 Dec; 40(18):1353-60. PubMed ID: 17931612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Palliative nutritional intervention in addition to cyclooxygenase and erythropoietin treatment for patients with malignant disease: Effects on survival, metabolism, and function.
    Lundholm K; Daneryd P; Bosaeus I; Körner U; Lindholm E
    Cancer; 2004 May; 100(9):1967-77. PubMed ID: 15112279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future.
    Argilés JM; Busquets S; García-Martínez C; López-Soriano FJ
    Nutrition; 2005 Sep; 21(9):977-85. PubMed ID: 16043325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tumor-host interactions.
    Tisdale MJ
    J Cell Biochem; 2004 Nov; 93(5):871-7. PubMed ID: 15449322
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Response to nutritional management in cancer patients].
    Sato N; Muto T
    Gan To Kagaku Ryoho; 1992 Mar; 19(3):302-7. PubMed ID: 1543358
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer.
    Perumal SS; Shanthi P; Sachdanandam P
    Cancer Chemother Pharmacol; 2005 Jul; 56(1):105-14. PubMed ID: 15726365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interventional nutrition for the cancer patient.
    Ogilvie GK
    Clin Tech Small Anim Pract; 1998 Nov; 13(4):224-31. PubMed ID: 9842115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management.
    Gadducci A; Cosio S; Fanucchi A; Genazzani AR
    Anticancer Res; 2001; 21(4B):2941-7. PubMed ID: 11712791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cachexia, survival and the acute phase response.
    Stephens NA; Skipworth RJ; Fearon KC
    Curr Opin Support Palliat Care; 2008 Dec; 2(4):267-74. PubMed ID: 19060563
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cancer cachexia.
    Kern KA; Norton JA
    JPEN J Parenter Enteral Nutr; 1988; 12(3):286-98. PubMed ID: 3292798
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Carbohydrate metabolism in cancer cachexia.
    Holroyde CP; Reichard GA
    Cancer Treat Rep; 1981; 65 Suppl 5():55-9. PubMed ID: 6809325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Carbohydrate and lipid metabolism in the cancer patient].
    Planas M; Porta I; Padró JB
    Nutr Hosp; 1994; 9(2):69-77. PubMed ID: 8031951
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cytokine-mediated alterations in host metabolism prevent nutritional repletion in cachectic cancer patients.
    Espat NJ; Moldawer LL; Copeland EM
    J Surg Oncol; 1995 Feb; 58(2):77-82. PubMed ID: 7844987
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amino acid metabolism in human cancer cachexia.
    Pisters PW; Brennan MF
    Annu Rev Nutr; 1990; 10():107-32. PubMed ID: 2200459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.